Literature DB >> 23754108

Eruptive xanthomas in a patient with severe hypertriglyceridemia and type 2 diabetes.

Barry Ladizinski, Kachiu C Lee.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23754108      PMCID: PMC3855120          DOI: 10.1503/cmaj.130148

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Cutaneous manifestations of systemic diseases.

Authors:  K J Robson; W W Piette
Journal:  Med Clin North Am       Date:  1998-11       Impact factor: 5.456

3.  Xanthomas and hyperlipidemias.

Authors:  F Parker
Journal:  J Am Acad Dermatol       Date:  1985-07       Impact factor: 11.527

  3 in total
  5 in total

1.  A young man with extensor eruptive skin lesions.

Authors:  Satishkumar Balasubramanian; Shriraam Mahadevan; Krishna Seshadri
Journal:  BMJ Case Rep       Date:  2015-12-18

2.  First and only symptom of undiagnosed diabetes mellitus: eruptive xanthoma.

Authors:  Berna Solak; Rabia Oztas Kara; Seyyid Bilal Acikgoz; Mustafa Kosem
Journal:  BMJ Case Rep       Date:  2015-09-24

3.  Eruptive Xanthoma with Acute Pancreatitis in a Patient with Hypertriglyceridemia and Diabetes.

Authors:  Tomoko Inoue-Nishimoto; Takaaki Hanafusa; Ayaki Hirohata; Eriko Kiyohara-Mabuchi; Naho Mizoguchi; Kohei Matsumoto; Sachiko Sakamoto; Masako Zenibayashi; Satoshi Miyata; Ryuta Ikegami
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

4.  Severe hypertriglyceridemia presenting as eruptive xanthomatosis.

Authors:  Sameera S Vangara; Kyle D Klingbeil; Raymond M Fertig; Jason L Radick
Journal:  J Family Med Prim Care       Date:  2018 Jan-Feb

5.  Insulin Treatment of Hypertriglyceridemia During Pregnancy.

Authors:  De-Cui Cheng; Yao Su; Feifei Li; Xianming Xu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.